Aktuelle Aussendungen (25 Treffer in 60 Monaten)
In Landmark Phase III Head-to-Head Study, Prasugrel Statistically Superior to Clopidogrel in Reducing Risk of Heart Attack
OTE0001 | 4. Nov. 2007, 14:04 | Channel: Wirtschaft | Aussender: Eli Lilly and Company
Investigational Once-Weekly Exenatide Demonstrated Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study
OTE0010 | 31. Okt. 2007, 14:15 | Channel: Wirtschaft | Aussender: Eli Lilly and Company
BYETTA(R) Study Showed Sustained Blood Glucose Control Over Three Years in People with Type 2 Diabetes
OTE0011 | 25. Juni 2007, 22:20 | Channel: Wirtschaft | Aussender: Eli Lilly and Company
Cialis(R) (tadalafil) for Once-a-Day Use Approved for the Treatment of Erectile Dysfunction by European Commission
OTE0003 | 25. Juni 2007, 13:42 | Channel: Wirtschaft | Aussender: Eli Lilly and Company
BYETTA(R) Study Showed Comparable Blood Glucose Control to Insulin
OTE0002 | 24. Juni 2007, 22:50 | Channel: Wirtschaft | Aussender: Eli Lilly and Company
BYETTA(R) Treatment for Three and a Half Years Associated with Sustained Improvements in Blood Glucose Control in People with Type 2 Diabetes
OTE0002 | 23. Juni 2007, 17:06 | Channel: Wirtschaft | Aussender: Eli Lilly and Company
Lilly and International Diabetes Federation Announce Launch of 'Inspired by Diabetes' Creative Expression Competition
OTE0006 | 21. Juni 2007, 16:58 | Channel: Wirtschaft | Aussender: Eli Lilly and Company
Clinical Data Suggest Potential Versatility of ALIMTA(R) (Pemetrexed for Injection)-Based Regimens in Lung Cancer
OTE0005 | 2. Juni 2007, 22:04 | Channel: Wirtschaft | Aussender: Eli Lilly and Company
Study Supports Activity of GEMZAR(R) (Gemcitabine HC1 for Injection) in the Treatment of Early-Stage Breast Cancer
OTE0003 | 2. Juni 2007, 21:05 | Channel: Wirtschaft | Aussender: Eli Lilly and Company
Lilly Announces a Call for Articles Into 2007 Luminous Award
OTE0006 | 1. Juni 2007, 14:11 | Channel: Wirtschaft | Aussender: Eli Lilly and Company
